Jaseok Peter Koo PhD
Associate Professor of Medicine (Medical Oncology)
Departments & Organizations
Cancer prevention and therapy; Lung carcinogenesis; Epithelial cell biology; Personalized medicine; Molecular targets; Drug development; Transcription Factor CREB; Inflammation; Cytokines and chemokines and receptors; Biomarkers for early detection and therapy more...
- Ph.D., University of North Carolina @ Chapel Hill, 1993
- Targeting vascular endothelial growth factor in patients with squamous cell lung cancer. Koo PJ, Morgensztern D, Boyer JL, Herbst RS. J Clin Oncol. 2012 Apr 1;30(10):1137-9
- Lee JS, Ryu SH, Kang SM, Chung WC, Gold KA, Kim ES, Hittelman WH, Hong WK, Koo JS. Prevention of Bronchial Hyperplasia by EGFR Pathway Inhibitors in an Organotypic Culture Model. Cancer Prev Res, 2011, Aug;4(8):1306-1315.
- Chung WC, Ryu SH, Sun H, Zeldin DC, Koo JS. CREB mediates prostaglandin F2alpha-induced MUC5AC overexpression. J Immunol 2009;182(4):2349-2356.